OrthoIndy channeling Walmart in comeback bid
The local orthopedic surgeons are presenting themselves as low-cost providers in an attempt to reverse growth restrictions imposed by Obamacare.
Life Science & Biotech
Articles
Expect deja vu: Obamacare won’t fix health care
By and large, Obamacare will leave in place the same major problems in the health care systems that existed before the law was passed—in both Indiana and across the nation.
Board suggested busy Evans let go of AIT
Michael Evans was juggling two companies and two newborn twins when his board of directors suggested it was time for a new CEO of AIT Laboratories. He was replaced by venture capitalist Matt Neff on Monday.
Already a wreck, the worst is yet to come with Obamacare
Obamacare is destined to fail for one key reason: it will make health insurance cost more and buy less.
Life sciences venture capital dips again
Venture capital surged in the first half of 2012, to $51.6 million in Indiana. But the pace of activity here fell off sharply in the second half of last year, and remained sluggish into 2013.
Relax, rejoice: Obamacare will revive health care
This is the first of three blog posts, each of which will make a compelling case for one of three distinct positions on Obamacare in Indiana: why it will succeed, why it will fail and why it will be a “non-event.”
Reworking Obamacare’s numbers: Half of Hoosiers to gain, half to lose
Digging into the filings by health insurers, I concluded that half of Hoosiers buying individual coverage next year on exchanges will pay less than before Obamacare. The other half will pay more.
Zimmer earnings fall on legal reserve costs
Zimmer Holdings saw second-quarter earnings slump 29 percent as the orthopedic device maker set aside an additional $47 million to cover the cost of lawsuits related to its Durom hip cups.
Dow AgroSciences posts record second-quarter sales
The Indianapolis-based maker of agricultural products, a unit of Michigan-based Dow Chemical Co., said revenue increased 10 percent from the year-ago period.
Amid Obamacare’s changes, WellPoint keeps old playbook
Even as it tries narrow networks, health insurer is trying to offer more choice of doctors now, but push for lower provider payments later.
Most individuals will pay less, not more, in Obamacare exchanges
Even with premiums doubling from 2012 to 2014, Obamacare’s subsidies will offset premium increases for most Hoosiers buying health insurance via the new federal exchanges.
Get ready to see for-profit religious hospitals
Hospitals already operate like for-profit businesses, but now a financial pinch is making more hospitals join their ranks. Aggressive moves by St. Vincent’s parent organization are just the beginning.
Would Medicaid expansion have saved hospital jobs?
As the Pence administration continues to negotiate with the feds, local hospitals say their recent cuts would not have been changed even if Indiana had expanded its Medicaid program.
There’s no reason for hospitals, doctors to lose the transparency debate
I launched The Dose with a post about the general use-lessness of the hopsital price data released in May by the Obama adminsitration. For what it's worth, the Journal of the American Medical Association, published by the nation's largest doctors' group, agrees with me. In a perspective piece published on July 10, http://jama.jamanetwork.com/article.aspx?articleid=1710451, JAMA contirbutor […]
Want Cliffs Notes on health reform? Look at Wishard
Soon to change its name to Eskenazi Health, the county-owned hospital in Indianapolis is using a business model that tries to promote patients’ health, rather than merely treat their diseases.
Obama hands employers free play on health insurance
The Obama administration’s one-year delay on enforcement of penalties against employers that fail to offer affordable health insurance gives employers the chance to cancel their benefits for the year and pocket a boatload of cash.
Call the midwife: Doctors, hospitals, patients all guilty of driving up childbirth costs
I can see the business model of the physicians and hospitals at work as they recommend tests of questionable necessity. Yet when it’s my own wife and son, it’s easy to think of a terrible outcome to avert with just one more test.
Universities’ patents often lack commercial applications
The state's universities crank out patents that find their way to pharmaceutical, prosthetics and surgery technology companies. But they also generate reams of patents in areas with few industrial applications.
Cook Group looking forward to next 50 years
For leaders of a company looking back on 50 years of existence, Cook Group President Kem Hawkins and Chairman Steve Ferguson spend a lot of time talking about the future.